openPR Logo
Press release

The Market of COVID- Vaccine is Estimated to more than 25 billion and More than 1.5 Billion Vaccines Have Been Injected To People Across The World

05-21-2021 11:39 AM CET | Health & Medicine

Press release from: Supply Demand Market Research

The Market of COVID- Vaccine is Estimated to more than 25 billion

More than 1.5 billion vaccines have been injected to people across the world. The pandemic that has hit world COVID-19 Vaccine. Different government agencies and several vaccine manufacturers to prevent human and economic losses due to the COVID-19 virus across the world is expected to boost the market's growth. Supply Demand Market Research consultant has evaluated the impact of different climate-related scenarios its different segments such as raw material supplier, demand of finished product, price etc. The tools combine by Supply Demand Market Research Intelligence’s data resources and credit analytics capabilities with Oliver Wyman’s climate scenario managing new financial risk.

To get a holistic SAMPLE of the report, please click @ https://www.supplydemandmarketresearch.com/home/contact/1582259?ref=Sample-and-Brochure&toccode=SDMRHE1582259

In such a medical emergency, after world war 2 first time the world have stand united to fight with the disease. The demand of PPE Kit, Oxygen mask and cylinder, Oxygen extractor or separator, mask, social distancing and sanitizer have been some essential product. The market of covid vaccine is estimated to more than 25 billion. At the end of the past decade and current decade has seen the Covid-19 pandemic which blown the world away from its normal life. Shutting down of transport facilities, lockdown, remote work, online classes, curfew are part and parcel of life since past one year. Millions of people have been affected by the disease and thousands have lost their life. Not a single country has been left which has not got impacted by this disease. Even the well-developed countries have suffered heavy losses.

Recent Updates on COVID-19 Vaccine

12 May 2021: Bharat BioTech's Covaxin gets SEC nod for phase 2,3 trials on children aged 2-18 years.

12 May 2021: Johnson and Johnson (U.S.) are looking for joint production of Johnson and Johnson Covid vaccine in India.

04 May 2021: Serum Institute plans to expand its vaccine business by pumping 240 Million pounds and set up new sales office in U.K.

To get this report at a profitable rate @ https://www.supplydemandmarketresearch.com/home/contact/1582259?ref=Discount&toccode=SDMRHE1582259

Global COVID- 19 Vaccine Market Revenue and Forecasts, By Type

Vector-based Whole Virus
Protein-based

Global COVID- 19 Vaccine Market Revenue and Forecasts, By Age Group

60+ Years & Above
45 - 60 Years
18 - 45 Years
0 - 18 Years

Global COVID- 19 Vaccine Market Revenue and Forecasts, By End-Use

Academic & Research Institutes
Vaccination Centers
Clinics
Hospitals
Others

Global COVID- 19 Vaccine Market Revenue and Forecasts, By Company

AstraZeneca
GlaxoSmithKline
Moderna
Gamaleya
Bharat Biotech
Pfizer
Johnson & Johnson
BioNTech
CureVac
Serum Institute of India
Novavax
Sinovac
Sinopharm

Buy Complete Copy of this Report Avail 20% Discount Use Coupon [SDMR20] @ https://www.supplydemandmarketresearch.com/home/purchase?code=SDMRHE1582259

Upcoming Vendors

AnGes
AIVITA Biomedical
CanSinoBio
EuBiologics
Genexine
GreenLight Biosciences
Gennova
Heat Biologics
INOVIO
IIBR, Medicago
Symvivo
Valneva
Zydus Cadila
Others

The customization research services cover the additional custom report features such as additional regional and country level analysis as per the client requirements.

Contact Us:

SUPPLY DEMAND MARKET RESEARCH

Mr. Charles Lee

302-20 Misssisauga Valley Blvd, Missisauga,

L5A 3S1, Toronto, Canada

Phone Number: +12764775910

Email- info@supplydemandmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Market of COVID- Vaccine is Estimated to more than 25 billion and More than 1.5 Billion Vaccines Have Been Injected To People Across The World here

News-ID: 2288040 • Views:

More Releases from Supply Demand Market Research

South Korea Flounder Market Anticipated to grow at a CAGR of 8% from 2023-2030
South Korea Flounder Market Anticipated to grow at a CAGR of 8% from 2023-2030
The South Korea flounder is anticipated to grow at a CAGR% of 8.0% from 2022-2030. The factors contributing towards the high growth are flounders such as halibut and turbot high-protein and low-calorie food, helps to re-solve the nutritional imbalance from diet because of its rich minerals, carbohydrates and vitamins despite low-calorie. They also offer medical benefits as liver of halibut contains lots of vitamin B1 and B2, which is effective
Global Flounder Market Anticipated to reach USD 56 Billion by 2030
Global Flounder Market Anticipated to reach USD 56 Billion by 2030
The global flounder market is anticipated to reach USD 56 Billion by 2030, growing at a CAGR% of 8.0% from 2022-2030. The factors contributing towards the high growth are flounders such as halibut and turbot high-protein and low-calorie food, helps to re-solve the nutritional imbalance from diet because of its rich minerals, carbohydrates and vitamins despite low-calorie. They also offer medical benefits as liver of halibut contains lots of vitamin
Global Seafood Market Anticipated to reach USD 730 Billion by 2030
Global Seafood Market Anticipated to reach USD 730 Billion by 2030
The global seafood market is anticipated to reach USD 730 Billion by 2030, growing at a CAGR% of 8.9% from 2022-2030. The factors contributing towards the high growth are increased disposable income, awareness of fish being used as an ingredient in healthy food is growing. USA the government plans to sanction illegal fishing activities, actively promote fair trade, and promote strategies to promote the fishing industry through detailed strategies such
Robotic Palletizers Market Is Expected to Reach US$11.98 Billion by 2033
Robotic Palletizers Market Is Expected to Reach US$11.98 Billion by 2033
The global robotic palletizers market is anticipated to reach $11.98 billion by 2033, presenting a 2023-2033 CAGR of 8.3%. The factors contributing towards the growth include the emerging Industry 4.0, a large scope for AI innovation, an increasing adoption of advanced industrial robotics to improve productivity and safety in manufacturing sectors, and the increasing government initiatives. The report is highlighted with 122 tables and 96 figures, this 209-page report "Global Robotic

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion